PURPOSE: Up to 15% of clinician-ordered doses of injectable pharmacological prophylaxis to prevent venous thromboembolism are not administered. Patient refusal accounts for nearly 50% of these omitted doses. We conducted a prospective cohort study to determine whether a patient education program would improve medication adherence to clinician-ordered injectable prophylactic anticoagulation. METHODS: We identified 528 hospitalized patients ordered to receive injectable pharmacological venous thromboembolism prophylaxis. We evaluated the impact of pharmacist-led patient education sessions on medication adherence (defined as the ratio of doses administered to doses scheduled) compared with our historical cohort. RESULTS: Individualized patient education sessions were conducted within 24 hours of the initial order for prophylactic anticoagulation in 99% of patients. Adherence to clinician-ordered pharmacological venous thromboembolism prophylaxis was higher after the patient education program than in our historical cohort (94.4% vs 89.9%, P <.0001). The proportion of patients receiving 100% of scheduled doses of injectable pharmacological venous thromboembolism prophylaxis was higher after our novel patient education program than in our historical cohort (73.7% vs 62.4%, P=.001). Patient refusal as a reason for omitted doses was less frequent after the patient education program (29.3% vs 43.7%, P=.001). CONCLUSION: Pharmacist-led individualized patient education sessions were associated with higher medication adherence to clinician-ordered injectable pharmacological venous thromboembolism prophylaxis and a reduction in patient refusal as a reason for omitted doses. A randomized controlled trial to evaluate the impact of a patient education program on medication adherence to pharmacological venous thromboembolism prophylaxis is warranted. Copyright Â
PURPOSE: Up to 15% of clinician-ordered doses of injectable pharmacological prophylaxis to prevent venous thromboembolism are not administered. Patient refusal accounts for nearly 50% of these omitted doses. We conducted a prospective cohort study to determine whether a patient education program would improve medication adherence to clinician-ordered injectable prophylactic anticoagulation. METHODS: We identified 528 hospitalized patients ordered to receive injectable pharmacological venous thromboembolism prophylaxis. We evaluated the impact of pharmacist-led patient education sessions on medication adherence (defined as the ratio of doses administered to doses scheduled) compared with our historical cohort. RESULTS: Individualized patient education sessions were conducted within 24 hours of the initial order for prophylactic anticoagulation in 99% of patients. Adherence to clinician-ordered pharmacological venous thromboembolism prophylaxis was higher after the patient education program than in our historical cohort (94.4% vs 89.9%, P <.0001). The proportion of patients receiving 100% of scheduled doses of injectable pharmacological venous thromboembolism prophylaxis was higher after our novel patient education program than in our historical cohort (73.7% vs 62.4%, P=.001). Patient refusal as a reason for omitted doses was less frequent after the patient education program (29.3% vs 43.7%, P=.001). CONCLUSION: Pharmacist-led individualized patient education sessions were associated with higher medication adherence to clinician-ordered injectable pharmacological venous thromboembolism prophylaxis and a reduction in patient refusal as a reason for omitted doses. A randomized controlled trial to evaluate the impact of a patient education program on medication adherence to pharmacological venous thromboembolism prophylaxis is warranted. Copyright Â
Authors: Oluwafemi P Owodunni; Brandyn D Lau; Michael B Streiff; Peggy S Kraus; Deborah B Hobson; Dauryne L Shaffer; Kristen L W Webster; Mujan Varasteh Kia; Christine G Holzmueller; Elliott R Haut Journal: Blood Adv Date: 2019-02-26
Authors: Kenneth M Shermock; Brandyn D Lau; Elliott R Haut; Deborah B Hobson; Valerie S Ganetsky; Peggy S Kraus; Leigh E Efird; Christoph U Lehmann; Brian L Pinto; Patricia A Ross; Michael B Streiff Journal: PLoS One Date: 2013-06-14 Impact factor: 3.240
Authors: Anthony D Yang; Daniel Brock Hewitt; Eddie Blay; Lindsey J Kreutzer; Christopher M Quinn; Kimberly A Cradock; Vivek Prachand; Karl Y Bilimoria Journal: Ann Surg Date: 2020-06 Impact factor: 13.787
Authors: Patricia N Apenteng; David Fitzmaurice; Ian Litchfield; Sian Harrison; Carl Heneghan; Alison Ward; Sheila Greenfield Journal: BMJ Open Date: 2016-12-13 Impact factor: 2.692
Authors: Brandyn D Lau; Dauryne L Shaffer; Deborah B Hobson; Gayane Yenokyan; Jiangxia Wang; Elizabeth A Sugar; Joseph K Canner; David Bongiovanni; Peggy S Kraus; Victor O Popoola; Hasan M Shihab; Norma E Farrow; Jonathan K Aboagye; Peter J Pronovost; Michael B Streiff; Elliott R Haut Journal: PLoS One Date: 2017-08-16 Impact factor: 3.240
Authors: Elliott R Haut; Jonathan K Aboagye; Dauryne L Shaffer; Jiangxia Wang; Deborah B Hobson; Gayane Yenokyan; Elizabeth A Sugar; Peggy S Kraus; Norma E Farrow; Joseph K Canner; Oluwafemi P Owodunni; Katherine L Florecki; Kristen L W Webster; Christine G Holzmueller; Peter J Pronovost; Michael B Streiff; Brandyn D Lau Journal: JAMA Netw Open Date: 2018-11-02